Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-001 · synthetic case FX-005

Pregnancy context with mild TSH elevation and Anti-TPO positivity

Pregnant, TSH 3.1 against a pregnancy range, Anti-TPO positive.

Synthetic · no real patientReviewed acceptance scenarioThyroid engine v1.1.0

Purpose: Route to pregnancy-specific pathway and prevent universal TSH >2.5 rule.

Inputs the engine received

Patient

Age and sex
31, female

Context

Pregnant
Yes

Symptoms

Fatigue
Present

Laboratory

TSH
3.1 mIU/L (ref 0.1–4)
FT4
1 ng/dL (ref 0.8–1.8)
ANTI-TPO
160 IU/mL (ref 0–35)

What the engine reports

Caution

Special Population Pathway

Pregnancy context identified. Use pregnancy-specific, trimester- and assay-appropriate interpretation where available. Do not apply a universal automatic treatment decision from the general engine.

Detected clinical pattern

No Biochemical Evidence of Current Thyroid Dysfunction from Entered TSH and FT4

Thyroid-function tests entered are within their reported laboratory reference intervals.

  • Etiology / context: Autoimmune Thyroiditis Supported

Why this pattern was identified

  • TSH and FT4 within reference. TSH 3.1 mIU/L (ref 0.1–4) and FT4 1 ng/dL (ref 0.8–1.8).
  • Autoantibody positive. Antibody positivity with normal TSH and FT4 does not itself indicate thyroid hormone treatment.
  • Pregnancy with Anti-TPO positivity and TSH 2.5–4.0. ATA guidance allows consideration of treatment in this range; the decision stays with the obstetric/endocrine physician.

Context modules routed

  • CTX-HT-PREG Pregnancy Thyroid Context

    Use trimester- and assay-specific reference intervals. No universal automatic treatment rule at TSH > 2.5. In TPO-positive pregnancy, ATA guidance recommends treatment above TSH 4.0 and allows consideration between 2.5 and 4.0, within a physician-managed obstetric/endocrine pathway.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Monitor thyroid function over time based on clinical context; antibody positivity alone is not a reason for thyroid hormone.
Evidence and rule trace · 2 rules

PR-HT-06Autoimmune Thyroiditis with Euthyroid Function

Inputs: ANTI-TPO 160 IU/mL (ref 0–35) · TSH 3.1 mIU/L (ref 0.1–4) · FT4 1 ng/dL (ref 0.8–1.8)

Autoimmune thyroiditis supported without current functional failure.

CTX-HT-PREGPregnancy Thyroid Context

Context module routed.

Evidence

  • EV-ATA-PREG · American Thyroid Association. Hypothyroidism in Pregnancy; based on ATA pregnancy guidance.
  • EV-ATA-HASHIMOTO · American Thyroid Association. Hashimoto's Thyroiditis.

Physician adjudication required. For clinician review only. This output identifies clinical patterns and safety considerations from the documented inputs. It does not establish an autonomous diagnosis or treatment plan. Physician confirmation is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Thyroid-function testsMove the sliders or type values
  • below range
  • within range
  • above range
  • below range
  • within range
  • above range
TSH3.1 mIU/L · within reference
ref 0.14
Free T41 ng/dL · within reference
ref 0.81.8
Where this sits on the TSH × FT4 plane
Overt primarySubclinicalDiscordantCentral?EuthyroidDiscordantCentral?Low TSHThyrotoxicTSH ↑FT4 →

Zones are drawn from your reference intervals. The engine, not the map, decides the pattern.

Laboratory values and reference rangesUse your lab's own interval
Ref. low
Ref. high

µIU/mL and mIU/L are numerically identical.

Ref. low
Ref. high
Ref. low
Ref. high

Interpreted against the reporting assay's upper limit.

Ref. low
Ref. high

Only used in the thyrotoxicosis pathway.

Ref. low
Ref. high
Ref. low
Ref. high
Ref. low
Ref. high
Ref. low
Ref. high
Patient context
Sex at birth
Medications and exposures
Symptoms and physical findingsSupportive only: never classify on their own

Symptoms

Signs and decompensation red flags

Live result · computed in your browser

Caution

Special Population Pathway

Pregnancy context identified. Use pregnancy-specific, trimester- and assay-appropriate interpretation where available. Do not apply a universal automatic treatment decision from the general engine.

Detected clinical pattern

No Biochemical Evidence of Current Thyroid Dysfunction from Entered TSH and FT4

Thyroid-function tests entered are within their reported laboratory reference intervals.

  • Etiology / context: Autoimmune Thyroiditis Supported

Why this pattern was identified

  • TSH and FT4 within reference. TSH 3.1 mIU/L (ref 0.1–4) and FT4 1 ng/dL (ref 0.8–1.8).
  • Autoantibody positive. Antibody positivity with normal TSH and FT4 does not itself indicate thyroid hormone treatment.
  • Pregnancy with Anti-TPO positivity and TSH 2.5–4.0. ATA guidance allows consideration of treatment in this range; the decision stays with the obstetric/endocrine physician.

Context modules routed

  • CTX-HT-PREG Pregnancy Thyroid Context

    Use trimester- and assay-specific reference intervals. No universal automatic treatment rule at TSH > 2.5. In TPO-positive pregnancy, ATA guidance recommends treatment above TSH 4.0 and allows consideration between 2.5 and 4.0, within a physician-managed obstetric/endocrine pathway.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Monitor thyroid function over time based on clinical context; antibody positivity alone is not a reason for thyroid hormone.
Evidence and rule trace · 2 rules

PR-HT-06Autoimmune Thyroiditis with Euthyroid Function

Inputs: ANTI-TPO 160 IU/mL (ref 0–35) · TSH 3.1 mIU/L (ref 0.1–4) · FT4 1 ng/dL (ref 0.8–1.8)

Autoimmune thyroiditis supported without current functional failure.

CTX-HT-PREGPregnancy Thyroid Context

Context module routed.

Evidence

  • EV-ATA-PREG · American Thyroid Association. Hypothyroidism in Pregnancy; based on ATA pregnancy guidance.
  • EV-ATA-HASHIMOTO · American Thyroid Association. Hashimoto's Thyroiditis.

Physician adjudication required. For clinician review only. This output identifies clinical patterns and safety considerations from the documented inputs. It does not establish an autonomous diagnosis or treatment plan. Physician confirmation is required.

More thyroid cases

All thyroid cases

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod